Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00446849 · ClinicalTrials.gov registry record · Phase 4
Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)
A Phase 4 study, sponsored by Shire.
- Completed
- Registry status
- Phase 4
- Development phase
- 290
- Enrollment target
NCT00446849 is a Phase 4 study that has completed, run by Shire. The registered enrollment target is 290 participants.
The verdict
NCT00446849, a Phase 4 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 290 participants
- Enrollment target
Study Summary
To evaluate the percentage of subjects with clinical recurrence of UC at 6 months using MMX mesalamine once daily.
Interventions
- DRUG MMX Mesalamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2007-05-01 |
| Est. Completion | 2009-08-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00446849
The ClinicalTrials.gov registry entry for NCT00446849 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MMX Mesalamine is the first listed.
NCT00446849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00446849 about?
NCT00446849 is a clinical study titled "Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)". To evaluate the percentage of subjects with clinical recurrence of UC at 6 months using MMX mesalamine once daily.
What is the current status of trial NCT00446849?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 290 participants. The study started on 2007-05-01. Estimated completion is 2009-08-17.
What interventions are being tested in trial NCT00446849?
The interventions under investigation include: MMX Mesalamine (DRUG).
Who is sponsoring clinical trial NCT00446849?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.